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Background: Despite a high prevalence of herbal and dietary supplement use (HDS) in pre-dialysis patients, the
reasons are unknown as to why they decide to use HDS. Objectives of the cross-sectional and qualitative studies
were to determine reasons for the use and non-use of HDS in Thai patients with chronic kidney disease (CKD).
Methods: This prospective study recruited 421 patients with stage 3–5 CKD from two kidney clinics in Thailand,
and 357 were followed up regarding their HDS use over 12 months. Patients receiving renal replacement therapy
at baseline were excluded. Participants were interviewed at baseline and in the twelfth month regarding their HDS
use, and reasons for their use or non-use of HDS. Among HDS users, 16 patients were enrolled in a qualitative study
and were interviewed using eight-open ended questions about reasons for HDS use. Descriptive and thematic analyses
were performed.
Results: Thirty-four percent of patients with CKD consistently used HDS over the 12 months and 17% of all patients
intermittently took them during the follow-up period. At baseline, family or friends’ recommendation was the most
common reason for HDS use (35%), followed by having a perception of benefits from using HDS (24%). During the
follow-up period, perceived benefits of HDS was a frequently reported reason for either continuing with HDS use
(85%) or starting to use HDS (65%). Negative experience from using HDS influenced patients to stop using them
(19%). Although the main reason for non-use of HDS was trust in a doctor or effectiveness of conventional medicine
(32%), doubt about the benefits from HDS or concerns about negative effects were frequently reported reasons for
non-use (23%). Doctor’s recommendations to avoid using HDS were the main influence for non-users (19%) and for
those who had stopped using HDS (23%). The media and patients’ social network had an impact on HDS use.
Conclusions: Patients who perceived benefits from HDS use were more likely to use HDS, whilst non-users had
negative attitudes towards HDS. Health professionals therefore should educate patients and their relatives about
the risks and benefits from using HDS.
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Use of herbal and dietary supplements (HDS) has risen
worldwide [1]. Patients with kidney diseases, such as
chronic kidney disease, dialysis, and kidney transplant-
ation, are more likely to use HDS (28%-57%) [2-5].
Most frequently reported reasons for using HDS or
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article, unless otherwise stated.patient populations are the perception of their benefits
and safety, dissatisfaction with conventional medicine,
and willingness to try them [6-17]. Cross-sectional stud-
ies are the main information source reporting this issue,
whilst there are limited qualitative studies [18-20].
Small numbers of surveys report reasons why patients
are unlikely to use HDS or CAM, that is, doubt about
their efficacy and safety, and satisfaction with conven-
tional medicine [15,21-23].
There are few surveys about reasons for HDS or CAM
use amongst patients with kidney diseases [2,4,24]. TheyCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 The interview questions about reasons for HDS
use
Eight-item interview questions
1. How and when were you introduced to HDS?
2. Why do you use HDS?
3. What led you to start using HDS?
4. Did anything influence you to start using HDS, e.g.
advice from friends, doctor, news reports, etc.?
5. Are there benefits of HDS compared with conventional
medicines? Please explain why you think this.
6. What did you hope taking HDS would achieve?
7. Do you have any concerns about using HDS? If yes, what?
Then please compare with conventional medicines.
8. Have you had any warnings about taking the HDS such
as from doctors, friends? If yes, has it influenced your
use in anyway?
Tangkiatkumjai et al. BMC Complementary and Alternative Medicine 2014, 14:473 Page 2 of 9
http://www.biomedcentral.com/1472-6882/14/473report that the perceived benefits and safety of HDS or
CAM are the main reasons for their use. Shah et al. (2013)
found CAM use was related to experiencing side effects
from conventional medicine (OR 9.59, 95% CI 2.77-33.20),
dissatisfaction with a doctor (OR 4.16, 95% CI 1.75-10.10)
and belief in a holistic approach (OR 3.20, 95% CI 1.58-
6.47) [24]. However, there is a lack of qualitative studies
conducted exploring this issue further. Therefore in this
paper, a combination of a survey and qualitative study
aimed to ascertain reasons why patients with chronic
kidney disease (CKD) use HDS. The secondary objective
of the survey was to determine reasons for non-use of
HDS. The patients were also followed up over 12 months
in order to observe decision-making process in HDS use
or non-use. These findings will guide health professionals
into fully understanding of HDS use in these patients and
prepare them to deal with this issue.
Methods
The survey
A prospective, cross-sectional study recruited 421 patients
with stage 3–5 CKD from two kidney clinics at teaching
hospitals in Thailand during January to June 2012. All
patients, in both settings, were approached by MT or
two trained interviewers, and informed about the pro-
ject, and asked for their consent. Patients receiving
renal replacement therapy before the recruitment were
excluded. Fifteen patients did not meet the inclusion
criteria due to three patients receiving dialysis and 12
patients having stage 2 CKD (estimated glomerular
filtration rate of approximately 60–65 ml/min/1.73 m2).
Of 406 patients recruited, 357 patients were followed up
regarding their HDS use, and any perceived beneficial and
detrimental effects of HDS over 12 months. Forty-nine
patients left the study due to death (n = 30) or lost
to follow-up (n = 19). Herbal and dietary supplements
were defined as products containing plant-derived
material, either raw or processed ingredients, from one
or more plants, or containing dietary ingredients, such
as vitamins, minerals, amino acids and substances, such
as, enzymes, organ tissues, glands and metabolites
[25,26]. Ethical approval was obtained from the Institu-
tional Review Board for Research in Human Subjects at
Faculty of Medicine, Chulalongkorn University and
Srinakharinwirot University in Thailand, and the Med-
ical School Research Ethics Committee, University of
Nottingham in the UK.
Patients were interviewed at baseline regarding their
HDS use, information sources, and reasons for HDS use
or non-use. The data collection was via a researcher-
administered questionnaire, which was developed and
validated by the authors [27]. The questionnaire used a
mixture of previously validated and new questions. In
the twelfth month, participants were interviewed overthe telephone about their HDS use and reasons for
continuing, stopping or starting HDS use since the
baseline survey. Simple frequencies with percentages
were used to determine reasons for HDS use and non-use.
The qualitative study
From the HDS users identified in the survey, the patients
who had provided details of the reasons for HDS use were
approached. If they consented to participate in the qualita-
tive study, they were recruited. Patients were recruited
and interviewed face-to-face until data saturation was
reached (n = 16). Eight open-ended questions about their
reasons for HDS use were developed based on literature,
see Table 1 [28,29]. This interview was piloted and it was
found that all participants (n = 6) understood and an-
swered the questions fully. This questionnaire was admin-
istered using face-to-face interviews. The interviews lasted
approximately 5–10 minutes and were audio recorded.
The audio recordings were transcribed verbatim and
the Thai transcripts were twice checked for accuracy
against the recordings before starting the process of
forward translation. Meaning-based translation from
Thai language to English language was performed and
English transcripts were twice checked with the Thai
transcripts [30]. Then five out of the sixteen transcripts
were backward translated by a bilingual person which
found one error. This was rectified.
The transcripts were analysed by inductive thematic ana-
lysis with line-by-line coding [31,32]. The Weft QDA, a
software programme for qualitative data analysis, was used
for assisting in the organisation of the transcripts [31,32].
Results
Demographic characteristics of participants are shown
in Table 2. Of 357 participants, 166 participants (46%)
had used HDS together with conventional medicines
in the last 12 months before the recruitment. Three
Table 2 Demographic characteristics of respondents in
the survey (n = 357) and qualitative study (n = 16)
Demographics The survey
(n = 357)
The qualitative
study (n = 16)
Frequency (Percentage)
Mean age and SD 66 ± 13 years 62.5 ± 12.3 years
Sex
Male 162 (45.4) 6 (37.5)
Female 195 (54.6) 10 (62.5)
Current address
Bangkok 132 (37.0) 6 (37.5)
Rural areas 225 (63.0) 10 (62.5)
Education
Primary or secondary school 254 (71.1) 8 (50.0)
Higher education 103 (28.9) 8 (50.0)
Table 3 Reasons for HDS use from both quantitative and qua
Quantitative results (n = 166)
Question Frequen
Reasons why HDS used (n = 271)*
Family/friend’s recommendation 95 (
HDS will work 65 (
Willing to try anything that helps 53 (
Prefer to use HDS 26 (
Health care provider’s recommendation 17
Safer than CM or no adverse effects from using
HDS, compared with CM
8 (
Easy access 4 (
Recommended by traditional practitioners or HDS sellers 2 (<
Recommended by fellow patients 1 (<
Information sources (n = 188)*
Family and friends 100
TV, radio, internet, leaflets, books or scientific evidence 59 (
Practitioners 18 (
HDS sellers 6 (
Own knowledge of HDS 4 (
Another patient with CKD 1 (
*Participants were able to report more than one reason or information source, so th
CM = Conventional medicine.
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users (34%, n = 123), non-users (49%, n = 177) and inter-
mittent users (17%, n = 60).
The most frequently reported reasons for HDS use in
the survey were due to family or friends’ recommenda-
tions (35%), followed by the expectation of gaining bene-
fit from using HDS (24%), see Table 3. Meanwhile, only
3% of users reported the safety of HDS as a reason for
HDS use. Regarding the qualitative findings, five themes
emerged on perceptions of HDS: patients’ health care
needs; perceptions of benefit and safety of HDS; willing-
ness to try HDS; and side effects of conventional medi-
cine (CM). Additionally, two further themes influencing
HDS use were recommendations from patients’ social
network and the media, see Figure 1. Such influences were
consistent with the findings from the survey; family, friends
and the media were most frequently reported as HDS infor-
mation sources, see Table 3. The main findings of thelitative studies at baseline
Qualitative results (n = 16)
cy (%)
35) Influenced by their social network who were health
care professionals or teachers (n = 9)
24) Perception of their benefits
20) (n = 11)
10) Health care needs (n = 7)
Willing to try (n = 4)
Intention to use (n = 2)
(6) No mention
3) Perception of their safety (n = 5)
Their characteristics
No or little side effects
Safer than CM
Had experiences or concerns about adverse effects
of CM (n = 2)
2) No mention
1) Their family recommended and then consulting Chinese
herbal medicine practitioners (n = 1)
1) Influenced by their social network (n = 9)
(53) Influenced by their social network (n = 9)
31) Influenced by the media (n = 9)
10) No mention
3) No mention
2) No mention
1) No mention
ese total more than 166.
Figure 1 Themes from interviews with 16 participants about their reasons for using HDS.
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professionals’ recommendation for HDS use and the ease
of access to HDS were not found in the qualitative study.
In the qualitative study, the media and the patients’ so-
cial network influenced patients to try HDS as they pro-
vided information about the benefits and safety of HDS
(Figure 1). Participants also seemed to respect educated
family members, friends and acquaintances, such as doc-
tors, nurses, and teachers, so they complied with their
recommendation to use HDS. Both the media and the
social network provided limited information about the
safety of HDS use in patients with CKD.
… a herbal company advertises on television that the
product is approved by the Thai FDA for a dietary
supplement… A herbal company advertises “This herb
is the best on sale product” “It is useful” “You would
not be disappointed”. (R13, m age 70)
My younger brother confirmed that HDS is good and
cleans the blood vessels, so blood circulation is
improved. He said “You should take it” “It does no
harm”. (R4, f age 56)He [my older brother who has a wife working as a
nurse and whose brother-in-law is a doctor] said “You
should eat these herbs, they are good”. (R13, m age 70)
You know, there is marked lack of warning about
taking herbs. (R11, f age 44)
However, some patients were concerned about renal
adverse effects of HDS, so they tended to use HDS with
caution and would consult with their health care pro-
viders if necessary.
If I take too many herbs, I’m afraid of worsening liver
and kidney function. (R7, m age 67)
Patients’ desire to improve, or at least stabilise their
condition was a drive for seeking alternative therapy, for
example avoidance of receiving dialysis and being able to
live their normal daily lives, such as being able to walk
and cook. As a result, some patients actively sought
HDS information, particularly about their benefits, and
decided to use HDS by themselves. They experimented
with HDS and monitored their effects. Where they
Table 4 Reasons why patients decided to use or stop
using HDS at the end point (n = 357)
Reasons Frequency (%)
Continuing to use HDS (n = 123)
Gaining benefit from using HDS 73 (59)
Expecting to gain benefit 32 (26)
To supplement their diet 8 (6)
Their family members or friends provided HDS 6 (5)
Recommended by their doctor 2 (2)
Used to take it 1 (1)
HDS is safe 1 (1)
Stopping HDS use (n = 43)
Recommended by their doctor 10 (23)
Having adverse effects from using HDS 8 (19)
Their minor ailments relieved 8 (19)
Do not want to use 5 (11)
Experience with no benefit from using HDS 3 (7)
Concern about adverse effects on kidneys 3 (7)
Cannot afford or not available 3 (7)
Receiving dialysis or their disease worsened 2 (5)
Taking high numbers of conventional medicines 1 (2)
Starting to use HDS (n = 17)
Expecting to gain benefit 11 (65)
Their family members or friends provided HDS 3 (18)
Their disease worsened 1 (6)
No reason given 2 (12)
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continue using them and where they did not, they would
stop using them. Others wanted to integrate HDS into
their mainstream treatment in order to increase the
efficacy of the conventional treatment.
I’m afraid of receiving dialysis… I want to use
everything, which helps me to avoid receiving
dialysis. (R8, m age 67)
I have to learn about herbal information by myself
and know about them from my colleagues’ or friends’
experiences of using herbs… I have to think whether or
not herbs suit me and decide to use them by myself.
(R11, f age 44)
I wanted to try them. After trying them, they were
good. Thus, I continue to use them. (R1, f age 59)
Conventional medicines are more effective than any
herbs. Herbs supplement conventional medicines.
(R12, m age 75)
Some patients reported using HDS due to dissatisfaction
with conventional medicine or had negative attitudes
towards it.
I had lots of side effects from conventional medicines,
so I turned my thoughts to herbal use and used it.
(R5, m age 43)
I’m afraid of worsening kidney function. If I take lots of
prescribed medicines, whether they will affect kidneys
or not? (R9, f age 46)
Regarding the follow-up study, reasons for continuing
or changing are shown in Table 4. The perception of
benefits from using HDS was the main reason for con-
sistent users (85%, n = 105) and new users (65%, n = 11).
Amongst 73 patients who continued using HDS due to
the benefits gained from using HDS, 31 patients (42%)
reported that they relieved minor ailments, such as
kariyat or vitamin C for the common cold, curcumin
for flatulence, senna or ‘Ka Sai’ as a laxative, and ‘Ya
Hom’ for dizziness. Twenty-five patients (34%) had
used dietary supplements for well-being, and perceived
such effects during the follow-up period. Examples of
such products were ginseng, essence of chicken drink,
fish oil, bee pollen, germ oil, swiftlet’s nest drink, and
botanical extracts. Other benefits from using HDS are
shown in Table 5. Neither negative experiences from
HDS use (26%, n = 11) nor negative attitudes towards
HDS (7%, n = 3) influenced continuing HDS use. Eight
patients experienced negative effects from using HDS,see Table 5. Three patients perceived no benefit from
using HDS, i.e. essence of chicken drink for tiredness,
seeds of Moringa oleifera for treatment of their chronic
illnesses, and mixed vegetable and fruit beverage for
diabetes, see Table 4.
Two patients were recommended by their doctor to
use fish oil for the prevention of cardiovascular disease,
vitamin E for CKD and vitamin C for the common cold.
Twenty-three percent (n = 10) of those who stopped
were advised by their doctor to avoid using HDS, i.e.
Thai traditional herbal remedies, Moringa oleifera, rice
bran oil, Chinese traditional medicine, curcumin, germ
oil and chlorophyll.
Reasons for non-use of HDS at baseline are shown in
Table 6. The most frequently cited such reasons were
either trust in their doctor or a belief in the benefits
from conventional medicine (32%, n = 62), followed by
health care professionals’ recommendations to avoid
HDS (19%, n = 36). Eight participants (5%) reported that
they had no particular reasons for choosing not to use
HDS.
Table 5 Herbal and dietary supplements and respondents’ experiences on benefits or adverse effects
Types of HDS (n = 14) Experience on benefits from using
HDS during the follow-up period
Three different types of mushrooms, jujube (Zizyphus mauritiana) and
roselle (Hibiscus sabdariffa), and Boesenbergia rotunda
Stable serum creatinine
A Chinese combination: Cordyceps, Angelica sinesis, deer antler velvet,
five flavour berry (Schisandra chinensis) and cinnamon
Stable serum creatinine
A herbal combination: Boesenbergia rotunda, mint, ginger, galangal,
lemongrass, kaffir lime leaves and shallots
Stable serum creatinine
Boesenbergia rotunda Stable serum creatinine
Boesenbergia rotunda and Chinese herbal medicine Stable serum creatinine
Moringa oleifera Stable serum creatinine
Blue pea (Clitoria ternatea) Stable serum creatinine
Spring bitter cucumber (Momordica cochinchinensis) and East Indian
screw tree (Helicteres isora)
Delay in receiving dialysis therapy
Vap ca (Houttuynia cordata) Diuretic effects
Lime (Citrus aurantifolia)
Clerodendrum petasites (n = 2) Diuretic effects
Bitter melon (Momordica charantia) Decreased blood sugar
Centella asiatica and Moringa oleifera Decreased blood pressure
Types of HDS (n = 8) Experience on adverse effects from using
HDS during the follow-up period
Protein supplements Proteinuria
Wheatgrass Tinnitus
Essence of chicken drink Increased blood sugar
Germ oil Increased body weight
River spiderwort (Tradescantia fluminensis) Increased serum creatinine
Unknown Thai traditional medicine Nausea
Thai herbal remedy containing aloe for laxative Increased serum creatinine
Thai traditional medicine for cancer called ‘Luke Klon’ Increased serum creatinine
Three unknown Thai or Chinese herbal remedies were reported on a benefit of stable serum creatinine.
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Over the 12 months of the study, most patients contin-
ued to use or not use HDS. It is clear that having either
an expectation or perception of gaining benefit from
using HDS was the most important factor influencing
patients with CKD to start or continue using HDS in the
present study. These findings are supported by a large
number of other surveys in patients with chronic ill-
nesses, including kidney diseases [4,8,14,15]. Several
studies in the US, Netherlands and Thailand also report
that patients complement their conventional medicine
with HDS similar to the findings in the present study
[7,10,12,13]. Some patients reported that they wanted to
use HDS combined with their conventional medicine for
incremental beneficial effects. This suggests that health
care professionals and researchers should investigate
how to integrate conventional medicine and HDS in
order to complement their benefits and avoid detrimen-
tal effects in patients with CKD.Meanwhile, patients who decided to stop, or not use,
HDS was largely due to either experiences of adverse
effects, a perception of no benefit from using HDS, or
having negative attitudes towards HDS. This is consist-
ent with a European survey in cancer patients [21]. In
addition, health care professionals’ recommendation for
avoiding HDS was a major influence on those who
stopped or did not use HDS in the present study. This
indicates that health care providers are likely to be a key
decision-maker for the group. Further studies need to be
investigated regarding the effect of the doctor-patient
relationship on patients with CKD and their decision to
use HDS or not.
In the current study, patients seemed to be motivated
to use HDS as a last resort when they were not satisfied
with what conventional medicine could achieve, such
as a desire to avoid dialysis therapy [6,14,19]. Benefit
and safety information about HDS were mainly pro-
vided by the media and patients’ family members or
Table 6 Reasons for not using HDS at baseline (n = 194)a
Reasons Frequency (%)
Patients trusted their doctor or trusted/needed to
use conventional medicines or perceived benefits
of conventional medicines are superior to HDS
62 (32)
Health care providersb advised that the patient
should not use HDS
36 (19)
Experiences or concerns about harm from HDSc 30 (16)
Doubt about benefits of HDS or experience with
no benefits from using HDS
14 (7)
Don’t want to use HDS 13 (7)
Taking a high number of conventional medicines 10 (5)
Had renal insufficiency, so patients concerned
about harm from HDS
9 (5)
HDS are expensive or HDS are not available in
their area
6 (3)
Patient’s relatives recommended that they should
not use HDS
5 (3)
Don’t know enough information about HDSd 4 (2)
They perceived that they are well 3 (2)
A book about kidney diseases indicated that CKD
patients should not use HDS
1 (1)
A patient need not use HDS if (s) he adheres to
medication and dietary recommendations for CKD
patients
1 (1)
aParticipants were able to report more than one reason, so these total more
than 191; Missing data was 15 participants (7.8%).
bDoctors or Pharmacists.
cAdverse effects of HDS, contaminated HDS, or HDS-conventional
medicine interactions.
dInformation about indications, doses, benefits, or risks of HDS.
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friends are an influencing factor in patient’s decision-
making regarding HDS use in Asian populations. This
is supported by other studies of CAM use amongst
patients with chronic diseases in Asian countries
[2,7,8,22,33,34]. This could be a result of the close knit
family culture in Asian countries. In comparison with
studies in Western countries which found that patients
with chronic illnesses used HDS if their health care
providers suggested it [4,10].
A systematic review has shown that the mass media
report positive effects of CAM rather than their negative
effects [35]. This is similar to our qualitative study where a
patient complained about the lack of warning about HDS
use in patients with renal insufficiency. Both health
care providers and policy makers, particularly in Thailand,
should be concerned about the potential impact, and
therefore information about both the risks and benefits
of using HDS should be widely available, particularly for
patients who may be more susceptible to adverse effects
from using HDS, such as those with CKD.
It appears that most patients in our study were inde-
pendent in their decision-making about HDS use as only asmall number of patients (6%) used it on the recommen-
dation of their health care provider. Some participants ac-
tively searched for information about the benefits and
safety of HDS and experimented with HDS by monitoring
efficacy and adverse effects. This is likely to be a common
process in the decision-making in patients who are inter-
ested in alternative therapy [29]. Health care professionals
should acknowledge this, and support access to appropri-
ate information for such patients together with monitoring
for any effects resulting from HDS use.
Safety of HDS (3%) was seen as less influential on
HDS use than their perceived benefit (24%) in our study.
Several users were concerned about the potential nega-
tive effects of HDS on their kidneys, so they used HDS
with caution, such as by reducing the dose of their HDS,
or only occasionally using HDS. This differs from Spanner
and Duncan’s study (2005) in Canada where they found at
least 3 in 4 patients with CKD thought that dietary supple-
ments caused no harm and improved their condition [4].
Likewise, people in the UK perceived that herbal medicine
is safer than conventional medicine [36]. It would seem
that Thai patients with CKD are more aware of detrimental
effects resulting from HDS use and avoid such effects in
their own way. Health care providers should be prepared
to advise these patients regarding how to safely use HDS.
Amongst patients who reported gaining benefits from
using HDS over the 12 months, three quarters perceived
that HDS either relieved their minor ailments, such as the
common cold, flatulence and constipation, or supple-
mented their diet. Also, respondents reported that their
doctor recommended fish oil for the prevention of cardio-
vascular disease, vitamin E for CKD, and vitamin C for the
common cold. These benefits have been supported by evi-
dence although there is controversy about such beneficial
effects from fish oil and vitamin C [37-40]. Vitamin E has
been recommended as a vitamin supplement when patients
with CKD stage 3 to 5 have a deficit in vitamin E [41].
Respondents perceived that several herbal medicines
could maintain their kidney function; however, the
majority of studies to prove this effect are in vitro.
Hibiscus sabdariffa, cordyceps, Zingiber officinale, shallots,
Moringa oleifera, Centella asiatica can inhibit angiotensin
converting enzyme, which is related to a decrease in
proteinuria, and then to slow the progression of CKD
[42-45]. This mechanism also supports Moringa oleifera
and Centella asiatica for antihypertensive effects reported
by respondents. Moreover, there has been no scientific
evidence to support some herbal medicines for main-
taining kidney function, such as Zizyphus mauritiana,
Boesenbergia rotunda, Clitoria ternatea, Momordica
cochinchinensis and Helicteres isora. Therefore, further
research, particularly clinical trials, needs to be conducted
regarding this issue before any recommendations can be
made.
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for diuretic effects have limited evidence in vitro [46,47].
Clerodendrum petasites has no scientific evidence to
support their diuretic effect. In contrast, a randomised,
controlled trial with a small number of patients with dia-
betic type 2 revealed that Momordica charantia decreased
glycated haemoglobin (A1C) greater than placebo [48].
This evidence is consistent with respondent’s report.
Almost all adverse effects from using HDS reported by
respondents have no further evidence to support their
statement. A respondent in the present study found that
Thai herbal remedy containing aloe was related to wors-
ening kidney function. This is consistent with a case
report; Cape aloe causes acute kidney injury [49]. ‘Luke
Klon’ is a dosage form of Thai herbal remedy and may
be contaminated with steroids [50], so this product may
induce kidney injury. Thus, health care providers and
patients should be aware of such detrimental effects.
The findings in this survey should be generalised with
caution due to only two hospitals being used as study sites,
although the study sample matches the Thai general popu-
lation in terms of gender, educational level, living in urban
or rural areas, smoking and drinking status [51]. Mean age
in the current study (66 years) was no different to other
studies of patients with CKD in Taiwan, the UK and Italy
(65–67 years) [52-54].
Conclusions
Positive attitudes towards herbal and dietary supple-
ments in patients with CKD were the main reasons for
HDS use, particularly their perceived benefit. Meanwhile,
negative attitudes towards HDS or negative experiences
from using HDS, including their doctor’s influence,
motivated patients not to use, or to stop, using HDS.
The media and patients’ social network seem to posi-
tively influence patients to use HDS. Thus, health care
providers and policy makers in Thailand should acknow-
ledge this influence and provide high quality information
about beneficial and detrimental effects of HDS use for
these patients. Further studies are required to investigate
the effect of the doctor-patient relationship on decision-
making regarding the use of HDS.
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